MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness


Condition: Prostatic Neoplasms, Genital Neoplasms, Male, Prostatic Diseases

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT01464216

Sponsor: Oslo University Hospital

Phase:

Eligibility:

  • Age: minimum N/A maximum N/A
  • Gender: Male

Inclusion Criteria:

  • Patients suitable for surgery with confirmed prostate cancer, Gleason grade ≥ 3
  • Patient has received no prior treatment for prostate cancer.
  • Patient has adequate renal function: Estimated creatinine clearance ≥ 60 ml/minute.
  • Patient must sign written informed consent according to the protocol approved by the Regional Ethics Committee.

Exclusion Criteria:

  • Patient with contraindication to MR or MR contrast media according to clinical practice.
  • Patients who want to withdraw for any reason during the study.
  • Patients previously undergone pelvic surgery or radiation therapy

View trial on ClinicalTrials.gov